WeVote
Log In

Bill

Bill

SB 191

Medical marijuana; expanding certain restrictions on certain advertising. Effective date.

2025 Regular Session Introduced by Dusty Deevers

Oklahoma expands medical marijuana advertising restrictions to limit how businesses market products, balancing patient protection with industry operational concerns.

Second Reading referred to Business and Insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 191

Legislative bill overview

SB 191 expands restrictions on advertising for medical marijuana products in Oklahoma. The bill modifies existing regulations governing how medical marijuana businesses can market their products to consumers. The measure includes an effective date provision for when these new advertising restrictions take effect.

Why is this important

Medical marijuana advertising regulations directly affect how patients access information about legal treatment options and how businesses can operate in this growing market sector. Stricter advertising rules could limit consumer awareness while potentially protecting vulnerable populations, but may also create competitive disadvantages or compliance burdens for licensed operators. Oklahoma's medical marijuana industry has become economically significant, so advertising policy impacts both patients and business viability.

Potential points of contention

  • Scope of restrictions unclear: The bill summary doesn't specify which advertising methods are restricted (social media, billboards, online platforms, etc.), making it difficult to assess the actual impact on businesses and patient access to information
  • Patient access vs. marketing concerns: Balancing protections against aggressive marketing with patients' legitimate need to learn about available treatments and providers
  • Competitive fairness: Restrictions may disproportionately affect smaller operators while larger corporations have resources to adapt to compliance requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.